Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Arizona Oncology - Scottsdale

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Sedona

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

3700 W State Route 89A
Sedona, AZ 86336
P: (928) 204-4163

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Tucson

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Glendale

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

7200 W Bell Road, Building A
Glendale, AZ 85308
P: (623) 487-4822

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Scottsdale

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

10460 N 92nd St, Suite 402
Scottsdale, AZ 85258
P: (480) 860-2540

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Randomized, Double Blind, Multicenter, Parallel-Group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men with Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy (SP005)

  • Details

ClinicalTrials.gov ID: NCT02111577
Diagnosis Type: NA
USOR Number: 13024

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Randomized, Double Blind, Multicenter, Parallel-Group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men with Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy (SP005)

  • Details

ClinicalTrials.gov ID: NCT02111577
Diagnosis Type: NA
USOR Number: 13024

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Tucson

ACE-LY-005: A Phase 1b/2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Hematologic Malignancies

  • Details

ClinicalTrials.gov ID: NCT02362035
Diagnosis Type: NA
USOR Number: 14184

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Melanoma

Clinical Trial at: Arizona Oncology - Tucson

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Chandler

FOCUS: A Multicenter, Multinational, Double-Blind, 2-Arm, Randomized, Phase 2/3, Study of Physician’s Choice Chemotherapy ([PCC] Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects with Platinum-Resistant, Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer (OX4325)

  • Details

ClinicalTrials.gov ID: NCT02641639
Diagnosis Type: NA
USOR Number: 16081

  • Practice Details

312 N. Alma School Rd., Suite 14
Chandler, AZ 85224
P: (480) 256-1689

More Details View Practice Page

Renal Cancer

Clinical Trial at: Arizona Oncology - Glendale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

7200 W Bell Road, Building A
Glendale, AZ 85308
P: (623) 487-4822

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer

  • Details

ClinicalTrials.gov ID: NCT02446600
Diagnosis Type: NA
USOR Number: 16043

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, AZ 85704
P: (520) 531-8967

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Arizona Oncology - Glendale

A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations (INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

7200 W Bell Road, Building A
Glendale, AZ 85308
P: (623) 487-4822

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

(USO 11025/ Novartis CBKM120ZUS39T) Phase II Multicenter Single-arm Study of BKM120 plus Capecitabine for Breast Cancer Patients with Brain Metastases

  • Details

ClinicalTrials.gov ID: NCT02000882
Diagnosis Type: NA
USOR Number: 11025

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Neuroendocrine Tumors

Clinical Trial at: Arizona Oncology - Scottsdale

A Phase 3, Prospective, Randomized, Double-Blind, Multi-Center, Study of the Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg plus BSC vs. Placebo plus BSC for Tumour Control in Subjects with Well Differentiated, Metastatic and/or Unresectable Typical or Atypical Lung Neuroendocrine Tumours (Spinet) - Ipsen A-US-52030-328

  • Details

ClinicalTrials.gov ID: NCT02683941
Diagnosis Type: NA
USOR Number: 15079

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10460 N 92nd St, Suite 402
Scottsdale, AZ 85258
P: (480) 860-2540

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Arizona Oncology - Glendale

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

7200 W Bell Road, Building A
Glendale, AZ 85308
P: (623) 487-4822

More Details View Practice Page

Pages